logo

For the Inventor, By the Inventor

Taipei, Taiwan

Jyh-Haur Chern

This inventor holds 10 USPTO granted patents and 1 EPO patent. Top assignee: National Health Research Institutes. Active years: 2004-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jyh-Haur Chern. Retrieved from https://idiyas.com/inventor/jyh-haur-chern

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10

% Patents Active = 30.0

 

Average Co-Inventor Count = 4.9

ph-index = 3

Forward Citations = 23(Granted Patents)


Company Filing History:

goldMedal10 out of 189 
 
National Health Research Institutes
 patents

Years Active: 2004-2013

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents
1. 8415482 - Proline derivatives (2013-04-09),
2. 8198284 - Treatment of neurodegenerative disorders with thiourea compounds (2012-06-12),
3. 7985763 - Hepatitis C virus inhibitors (2011-07-26),
4. 7939523 - Imidazolidinone and imidazolidinethione derivatives (2011-05-10),
5. 7897764 - Thiourea derivatives (2011-03-01),
6. 7501445 - Imidazolidinone compounds (2009-03-10),
7. 7259174 - Imidazolidinone compounds (2007-08-21),
8. 7129359 - Imidazolidinone compounds (2006-10-31),
9. 6815444 - Anti-enterovirus compounds (2004-11-09),
10. 6706739 - Imidazolidinone compounds (2004-03-16),

Title: Innovations and Contributions of Jyh-Haur Chern

Introduction

Jyh-Haur Chern is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of medical research, particularly in the development of compounds for treating viral infections and neurodegenerative disorders. With a total of 10 patents to his name, Chern's work has the potential to impact the lives of many patients.

Latest Patents

Chern's latest patents include innovative compounds that are useful for treating hepatitis C virus infection. These compounds are defined by a specific formula, which includes various variables that are detailed in the patent documentation. Additionally, he has developed a method for treating neurodegenerative disorders using thiourea compounds. This method involves administering an effective amount of these compounds to subjects in need, aiming to reduce microglia-mediated neuro-inflammation and enhance microglial phagocytosis of amyloid-beta.

Career Highlights

Chern is affiliated with the National Health Research Institutes, where he conducts his research and development work. His career is marked by a commitment to advancing medical science and improving treatment options for patients suffering from serious health conditions.

Collaborations

Chern has collaborated with notable colleagues, including Yen-Chun Lee and Chung-Chi Lee, to further his research efforts. These collaborations have contributed to the success of his projects and the advancement of their shared goals in medical innovation.

Conclusion

Jyh-Haur Chern's work exemplifies the spirit of innovation in the medical field. His patents and research efforts are paving the way for new treatments that could significantly improve patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…